#United States #Charlotte #Private Equity #dermatology #TUSK Practice Sales

Strong Demand for Dermatology Practices

The dermatology sector has shown remarkable resilience amidst broader fluctuations in the healthcare industry. TUSK Practice Sales has recently published its Q3 2026 Dermatology Market Report, indicating a stable trajectory in mergers and acquisitions (M&A) within the dermatology field, even as overall healthcare transaction volumes saw a notable decline of 16% year-over-year. This divergence highlights the unique appeal and ongoing investor interest that dermatology practices command.

Key Findings from the Report

According to the report, the demand for dermatological services is robust and is expected to continue growing, driven by demographic trends such as an aging population and an increasing number of skin cancer diagnoses. With approximately 9,500 new skin cancer cases identified daily in the United States, the dermatology services market, valued at $63 billion in 2023, is projected to nearly double to about $128 billion by 2033—reflecting a compound annual growth rate of 7.3%.

Ryan Mingus, Managing Director and Partner at TUSK, emphasized the factors propelling this market vitality: "Despite broader challenges, dermatology practices have managed to retain their value, driven by buyer demand for quality operational practices. Well-run practices showing diversified service offerings are particularly sought after."

Recapitalization Waves and State Laws

The report also sheds light on the ongoing recapitalization trend within the dermatology space. As many private equity (PE) backed dermatology platforms near the five-year mark, they now seek recapitalization events, reintroducing fresh capital into the market and intensifying competition among potential buyers. New state legislation, including measures like Oregon's SB 951 and California's SB 351, is reshaping the landscape by easing corporate ownership restrictions, thereby directing interest toward states with fewer regulatory hurdles.

Competitive Landscape

Current trends reveal that buyers are particularly focused on practices with substantial earnings before interest, taxes, depreciation, and amortization (EBITDA) exceeding $500,000. These practices not only draw the greatest competition but also provide owners with leverage in negotiations. The evolution from platform-centric acquisitions to add-on purchases marks a significant shift, as existing buyers concentrate on enhancing their current holdings.

Market Forces at Play

Several critical forces are currently shaping the dermatology M&A landscape:
1. Add-ons Are Powering Growth: In recent times, the strategic focus has moved away from creating new platforms toward acquiring add-ons to expand existing entities.
2. The Recapitalization Wave is Active: A significant number of PE-backed platforms are now five or more years old, leading to an influx of competition and funding as they seek growth through acquisitions.
3. Discipline is Essential: The tightening financial environment, particularly high debt costs, causes buyers to be more judicious about their acquisitions, tightening deal structures.
4. Geographical Considerations Matter More: As legislative changes impact ownership structures, investors are increasingly cautious about entering states with strict regulations. Dermatologists located in states with heavy restrictions may find fewer bidders for their practices, complicating their selling positions.

Insightful Recommendations for Dermatologists

For dermatologists contemplating a sale or partnership, understanding the various dimensions of practice transactions is essential. The report outlines a comprehensive review of different facets of offers, including cash payments at closing, escrow arrangements, compensation post-sale, joint ventures, and more. Mingus noted, "As competition increases for quality dermatology practices, sellers need to be informed about their market position to make wise decisions related to potential offers."

As we steer into the second half of 2026, expectations of heightened acquisition activity loom large, particularly as seasoned groups inject fresh capital into the market. The implications for dermatology practice owners are significant as they navigate a landscape rich with opportunities yet fraught with strategic challenges. For detailed insights and the full report, access is available through TUSK Practice Sales' online platform.

Conclusion

In summary, the dermatology sector's ability to thrive amid a tumultuous healthcare landscape indicates strong fundamentals and continued commitment from private equity investors. The opportunity for practice owners to capitalize on their success is ripe, provided they approach the market with informed decisions and strategic foresight.